1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival
2023) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41(10). p.1849-1863(
- Contribution to journal › Article
-
Mark
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival
(
- Contribution to journal › Article
- 2021
-
Mark
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
(
- Contribution to journal › Article
- 2020
-
Mark
Evaluation of associations between genetically predicted circulating protein biomarkers and breast cancer risk
(
- Contribution to journal › Article
-
Mark
Genetically Predicted Levels of DNA Methylation Biomarkers and Breast Cancer Risk : Data From 228 951 Women of European Descent
(
- Contribution to journal › Article
- 2019
-
Mark
Two truncating variants in FANCC and breast cancer risk
(
- Contribution to journal › Article
-
Mark
The association between weight at birth and breast cancer risk revisited using Mendelian randomisation
(
- Contribution to journal › Article
- 2016
-
Mark
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
(
- Contribution to journal › Article
-
Mark
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.
2016) In Nature Genetics(
- Contribution to journal › Article
-
Mark
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer
(
- Contribution to journal › Article